22 January 2018

I’ve just started PrEP, here’s how my first hook up went

He’ll be here soon. We’ve had sex before, but I wasn’t on PrEP back then. How’s he going to respond when I tell him, and what’s going to happen?
17 January 2018

Long-acting injectable ARVs are convenient and private, study participants report

HIV-positive people who took injectable cabotegravir + rilpivirine every four or eight weeks as antiretroviral therapy found it more convenient and discreet than daily pills, also feeling that it eliminated a “daily reminder of living with HIV”, Deanna Kerrigan and colleagues report in PLOS One. Similarly, HIV-negative men who took injectable cabotegravir every 12
16 January 2018

My PrEP story: Phil (part 1)

My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.
16 January 2018

Alberta considers funding HIV prevention drug, in what could be 'tipping point' in epidemic

After years of urging the province for changes, sexual health advocates are hopeful Alberta will finally fund an expensive drug that can prevent the spread of HIV.
15 January 2018

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men acknowledged that they did not always use condoms but did not see themselves as the kind of ‘barebacker’ for whom they thought PrEP was
10 January 2018

'Thinking About Sex?' DC Uses Racy Ad to Promote Anti-HIV Drug

Health officials hope the provocative campaign will increase awareness of a drug that reduces the risk of HIV by over 90 percent.
9 January 2018

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

A new oral device that is taken once a week in a capsule could deliver two or three antiretroviral drugs and significantly reduce the risk of missing does or of developing drug resistance, according to research published today in Nature Communications. The investigators describe their device as a 'mini-pillbox' – no
9 January 2018

Usage remains low for pill that can prevent HIV infection

From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which — in their view — remains woefully underused.
8 January 2018

Kenya: HIV prevention pill yet to catch on

Months after the launch of PrEP as a HIV-prevention measure, uptake is still lower than expected
7 January 2018

New Online Resource For PrEP Created By Dublin-Based Activists

Will St Leger, Adam Shanley and several other sexual health advocates have collaborated to create a site full of everything you need to know about PrEP in Ireland.
5 January 2018

Why Going Bareback Was The Best Sex Decision I Ever Made

I no longer use condoms and I have no regrets. Evidence now suggests that, if you take PrEP daily, as I always do, the risks of HIV infection is roughly the same, or lower, than condoms, and I’ve rediscovered a world of pleasure denied to me for more than 30 years.
3 January 2018

Florida to Roll Out Free PrEP in 2018

All 67 county health departments will offer the daily HIV prevention pill Truvada. Several already do.
31 December 2017

British Columbia will now offer a daily drug that prevents HIV — for free

The BC Ministry of Health will begin covering PrEP at no cost on Jan 1, 2018. The province’s new access to PrEP is in part thanks to a deal worked out between the BC Centre for Excellence in HIV/AIDS and generic manufacturers of the drug.
23 November 2017

To better target HIV prevention, identify people whose social contacts have high viral loads

Rather than relying on assessment of an individual’s sexual behaviour or of ‘community viral load’, targeting of pre-exposure prophylaxis (PrEP) and other prevention interventions could in part be based on the proportion of a person’s social contacts who have unsuppressed HIV. There is a correlation between young gay men having HIV and their ‘network
13 November 2017

Up to a quarter of HIV-negative gay men attending three English clinics used PrEP in the last year

A prospective cohort study of gay men attending three clinics in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service – have found that 23% of HIV-negative service users who responded to a follow-up questionnaire had used PrEP (pre-exposure prophylaxis)
8 November 2017

High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study

HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside the main relationship, was high, and very high in partners who admitted having condomless anal sex with non-primary partners, the 16th European AIDS Conference (EACS 2017) heard recently. The conference heard
1 November 2017

Survey of dating app users finds that PrEP usage has not increased in Europe in the last year

A study of men who have sex with men (MSM) conducted by the European Centre for Disease Prevention and Control (ECDC) in collaboration with the gay contact site Hornet has found that pre-exposure prophylaxis (PrEP) usage has not increased, on average, among its respondents over the proportion reported last year, when a similar survey
26 October 2017

How a London clinic reduced new HIV infections by 90% and why more European cities can do the same

Scaling up HIV testing to reduce undiagnosed HIV infection requires a fundamental re-ordering of HIV testing services to make them more attractive to people at risk, and doing so can bring about enormous changes in HIV incidence and treatment uptake, delegates heard on the opening day of the 16th European AIDS Conference (EACS 2017)
23 October 2017

A year of generic PrEP could recoup its own cost within five years if effectiveness is high, Public Health England model finds

A cost-effectiveness model developed by Public Health England finds that just one year’s worth of pre-exposure prophylaxis (PrEP), given to gay men during a period of moderate to high HIV risk, would recoup its own costs and save the NHS money within 23 years if PrEP effectiveness was as high
17 October 2017

PrEP would save the NHS money, in numerous scenarios

A pre-exposure prophylaxis (PrEP) programme for men who have sex with men in the UK would not only be cost-effective, but actually cost-saving (in other words, both improving health and lowering NHS spending), according to an economic evaluation published by Valentina Cambiano and colleagues in The Lancet Infectious Diseases today.Modifying a wide range|KQXCFiDUEK_aJbZ3ABTaS2hE1o0&limit=10Array ( )